Johnson & Johnson

06/23/2021 | Press release | Distributed by Public on 06/23/2021 07:47

Janssen Submits New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients